#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16008	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2238	711.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1512	1512	C	989	C	916	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16008	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2238	711.8	0	HET	.	.	.	A37T	.	37	37	A	365	365	A	912	A,T	693,154	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28782	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3385	846.4	0	.	n	.	0	A20C	SNP	20	20	A	267	267	C	504	C,A	484,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28782	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3385	846.4	0	.	n	.	0	T695C	SNP	695	695	T	942	942	C	913	C,T	849,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28782	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3385	846.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1885	1885	G	967	G,T	899,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28782	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3385	846.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2218	2218	C	934	C	867	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28782	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3385	846.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2292	2292	A	965	A	918	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28782	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3385	846.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2844	2844	C	937	C,T	874,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1956	folP	855	855	100.0	folP.l15.c4.ctg.1	1456	133.6	1	SNP	p	R229S	1	.	.	685	687	AGC	940	942	AGC	202;203;203	A;G;C	190;189;188	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3327	150.8	1	SNP	p	S91F	1	.	.	271	273	TTC	531	533	TTC	164;164;164	T;T;C	151;151;146	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3327	150.8	1	SNP	p	G95N	0	.	.	283	285	GGC	543	545	GGC	172;173;174	G;G;C	154;159;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3327	150.8	1	SNP	p	D95G	1	.	.	283	285	GGC	543	545	GGC	172;173;174	G;G;C	154;159;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	27	1706	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1347	126.3	1	SNP	p	G45D	0	.	.	133	135	GGC	503	505	GGC	221;219;220	G;G;C	202;200;205	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	834	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1103	75.1	0	.	n	.	0	.206T	INS	206	206	T	597	597	T	200	T	189	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3017	170.6	1	SNP	p	D86N	0	.	.	256	258	GAC	585	587	GAC	191;194;194	G;A;C	174;175;181	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3017	170.6	1	SNP	p	S87R	1	.	.	259	261	CGT	588	590	CGT	192;192;195	C;G;T	180;179;180	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3017	170.6	1	SNP	p	R87I	0	.	.	259	261	CGT	588	590	CGT	192;192;195	C;G;T	180;179;180	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3017	170.6	1	SNP	p	R87W	0	.	.	259	261	CGT	588	590	CGT	192;192;195	C;G;T	180;179;180	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5170	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3017	170.6	1	SNP	p	S88P	0	.	.	262	264	TCC	591	593	TCC	197;198;197	T;C;C	181;182;182	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4248	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2503	168.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1510	1512	GGC	233;227;225	G;G;C,A	212;207;201,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1262	1264	GCA	218;219;218	G;C;A	204;203;204	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1265	1267	ATC	215;215;218	A;T;C	203;201;204	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1277	1279	GTG	224;219;219	G;T;G	205;197;200	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1277	1279	GTG	224;219;219	G;T;G	205;197;200	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1781	1783	ACC	207;204;204	A;C;C	187;190;191	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1835	1837	GCG	196;196;194	G;C,G;G,C	172;161,3;166,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1835	1837	GCG	196;196;194	G;C,G;G,C	172;161,3;166,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1958	1960	AGC	183;183;182	A;G;C	169;168;168	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1967	1969	GGC	168;167;167	G;G;C	155;151;153	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4112	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2375	172.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1985	1987	CCG	141;142;146	C;CG,CGG;GCCC,GGCCCC	112;108,1;112,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5890	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3106	189.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1622	1624	CCG	196;196;200	C;C;G	173;177;181	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2028	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1924	104.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	652	652	C	148	C	129	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	276	porB1a	984	287	90.03	porB1a.l6.c30.ctg.1	355	15.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	91	93	AAT	9;9;9	A;A;T	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	276	porB1a	984	287	90.03	porB1a.l6.c30.ctg.1	355	15.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	94	96	AAT	9;9;10	A;A;T	9;9;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	276	porB1a	984	287	90.03	porB1a.l6.c30.ctg.1	355	15.2	0	.	p	.	0	A222V	NONSYN	664	666	GCT	106	108	GTT	8;8;9	G;T;T	8;8;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	276	porB1a	984	287	90.03	porB1a.l6.c30.ctg.1	355	15.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	118	120	GCG	8;8;8	G;C;G	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	276	porB1a	984	287	90.03	porB1a.l6.c30.ctg.1	355	15.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	141	143	GTA	9;9;9	G;T;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	276	porB1a	984	287	90.03	porB1a.l6.c30.ctg.1	355	15.2	0	.	p	.	0	N237K	NONSYN	709	711	AAC	150	152	AAA	9;9;9	A;A;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	276	porB1a	984	287	90.03	porB1a.l6.c30.ctg.1	355	15.2	0	.	p	.	0	D238fs	FSHIFT	712	712	G	153	153	G	9	G	9	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1606	198.4	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	843	845	CAA	254;252;252	C;A;A	236;238;235	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1606	198.4	0	.	p	.	0	E212S	NONSYN	634	636	GAA	1050	1052	AGT	251;249;247	A;G,T;T	244;241,1;237	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1606	198.4	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1053	1055	GAT	249;251;249	G;A,T;T	237;240,1;240	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1606	198.4	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1059	1061	GCT	252;249;249	G;C;T,A	245;244;243,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1606	198.4	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1068	1070	ATG	252;252;247	A;T;G	246;244;240	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1606	198.4	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1185	1187	AAG	288;288;281	A,T;A,G;G	266,1;265,1;260	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1606	198.4	1	SNP	p	G120K	0	.	.	358	360	GGC	774	776	GGC	257;254;255	G;G;C	240;235;235	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12156	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5005	242.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1310	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1257	104.0	1	SNP	p	V57M	1	.	.	169	171	ATG	688	690	ATG	281;282;285	A;T,C;G	267;264,1;270	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
